Antimetastatic efficacy of oral 5-FU imaged by green fluorescent protein in real time.
The effectiveness of oral 5-FU in suppressing liver metastasis was assessed in a highly-metastatic mouse model. Doses of 20 and 25 mg/kg oral 5-FU significantly suppressed primary and metastatic tumor growth (p = 0.012). These inhibitory effects were more dramatic in suppressing liver metastasis (p = 0.0). The efficacy of 5-FU was visualized by whole-body fluorescence imaging of the green fluorescent protein-expressing tumor and its subsequent metastases. Toxicity was observed only in the 30 mg/kg dose. Furthermore, we showed that the non-toxic doses of 5-FU significantly prolonged survival in these animals. These data suggest the important clinical potential of oral 5-FU.